Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Technology-Based Physical Activity PromotionBehavioral: Pedometer Intervention
- Registration Number
- NCT01837147
- Lead Sponsor
- University of California, San Diego
- Brief Summary
Women who are overweight or do not exercise are at higher risk for breast cancer after menopause. This study will test a new electronic device that measures the body's movement and works alongside a website to help women increase their physical activity level. If effective, this system could be tested in larger studies aiming to reduce breast cancer risk by reducing or preventing obesity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 51
- Female
- Postmenopausal
- BMI >= 25.0 kg/m2
- Physically inactive
- Internet user with regular access to high-speed internet
- Willing and able to complete study requirements
- History of invasive breast cancer
- Medical contraindication to exercise
- Medical problem or other issue that would interfere with intervention
- Current participation in another physical activity study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Web-based Tracking Group Technology-Based Physical Activity Promotion Technology-Based Physical Activity Promotion Pedometer Group Pedometer Intervention Participants assigned to this group will receive a pedometer.
- Primary Outcome Measures
Name Time Method Change in objectively-measured physical activity Baseline to 16 weeks Assessed using ActiGraph.
- Secondary Outcome Measures
Name Time Method Self-reported physical activity Baseline to 16 weeks Assessed using questionnaires.
Body weight (kg) Baseline to 16 weeks Measured in clinic.
Uptake of technology-based intervention components During 16-week intervention To be assessed via data downloaded from the website used in this study.
Quality of life Baseline to 16 weeks To be assessed via self-report questionnaire.
Trial Locations
- Locations (1)
Moores UCSD Cancer Center
🇺🇸La Jolla, California, United States